HSCNews International 2010

Health and Social Campaigners' News International is a unique, monthly service designed to give the 4,000 members of the Health and Social Campaigners' Network practical information about the policies and activities of patient and disability groups worldwide.

HSCNews International is available on subscription to members of the public who may not qualify for membership of the HSCNetwork International but who are interested in reading about health and social campaigners.

Issues of HSCNews International contain:

· Independent and balanced analysis of health advocacy worldwide ( HSCNews concentrates on what advocates and their groups are thinking, what they are doing, and what they plan to do).
· A focus on topics at the top of the agenda of patient, disability and carers' groups.
· Interviews on policy and strategy matters with leading campaigners.
· Summary results of in-house surveys. (These simple surveys are conducted among the databank established during the setting up of the HSCNetwork, which includes 90,000 health advocacy representatives and patients from around the globe. The surveys enable health and disability campaigners to express their views on subjects of importance to them, and results are published in HSCNews International.)

--------------------------------------------------------------------------------------------------------

Issue 53, HSCNews International (March 2010)
Patient groups’ views of the pharma industry in 2009
What this issue contains:

HSCNews International continues to report on the results of its December 2009 annual review of patient group opinions of the pharmaceutical industry. 665 patient groups from 47 countries told HSCNewswhat they thought about the industry in 2009. This issue contains patient groups’ opinions on the extent to which pharma companies have been able to improve relationships with patient groups by providing nine broad categories of help to patient groups. Patient groups also assess whether pharma companies have supported patient-group campaigning capacity in five potential subject areas. In addition, patient groups consider pharma’s effectiveness at providing seven types of patient-oriented information. Patient groups judge whether pharma has produced corporate strategies aimed at helping poorer patients who have been financially adversely affected by the 2009 global recession. Patient groups’ opinions of pharma have allowed HSCNews to rank the world’s top-15 pharma companies for their effectiveness in four different categories of patient-oriented activity: information provision; handling relationships with patient groups; trustworthiness; and understanding patients’ needs. Finally, various patient groups offer their individual opinions on most of the top-15 companies.

For a March 2010 Financial Times article on the results of this issue, please go to click here

cover of HSCNews International,
issue 53, March 2010
 Patient groups’ views of the
pharma industry in 2009


Google

 

 

 

 

--------------------------------------------------------------------------------------------------------

Issue 52, HSCNews International (January 2010)
Patient groups’ views of the pharma industry in 2009
What this issue contains:

HSCNews International reports on the results of its December 2009 annual review of patient group opinions of the pharmaceutical industry. 665 patient groups from 47 countries told HSCNews what they thought about the industry in 2009. The patient groups’ opinions have allowed HSCNews to analyse pharma industry trends during 2009 across five regions of the world (Australasia; Western Europe; Eastern Europe; North America; and Latin America), and in six medical specialties (common cancers; rare cancers; diabetes; HIV/AIDS; mental health; and neurological conditions). The patient groups replying to the annual review commented on the quality of pharma company relationships with patient groups in 2009. They also gave their views on pharma performance in 2009, according to seven patient group-oriented indicators (innovating to meet patients’ needs; providing information to patient groups; creating relationships with patient groups; being transparent about relationships with patient groups; being trustworthy; managing conflicts of interest; and managing adverse news about products). Finally, the 665 patient groups considered pharma’s record in 2009 on various activities (innovation; marketing; truthfulness and accuracy in communications to patients; ensuring product safety; disease-awareness campaigns; pricing policies, and getting products reimbursed). Where possible, HSCNews has compared the results from this 2009 annual review with those of the previous year (2008), to highlight changing trends.

cover of HSCNews International,
issue 52, January 2010
 Patient groups’ views of the
pharma industry in 2009

--------------------------------------------------------------------------------------------------------

How to subscribe to HSCNews International
HSCNews International is a free service to the members of the HSCNetwork International.
If you do not work as a campaigner in the fields of health or disability, but you still wish to receive HSCNews International, you can become a subscriber. Please email your request to info@patient-view.com.

HSCNetwork International . ..HSCNews International in 2009. ..HSCNews International in 2008
HSCNews International 2007 . ..HSCNews International 2006 . ..HSCNews International in 2005
HSCNews International in 2004 .. HSCNews International in 2003

PatientView, Woodhouse Place, Upper Woodhouse, Knighton, Powys, LD7 1NG, Wales
Tel: 0044-(0)1547-520-965 · E-mail: info@patient-view.com
Registered in England No 3944382
Registered office: Millennium Bridge House, 2 Lambeth Hill, London, EC4 4AJ, UK